Conclusion of a non-exclusive rebate agreement under Section 130a(8) of the German Social Code Book V for the active substance Roxadustat, ATC B03XA05, for the period 01/06/2026 - 31/05/2028

Summary

The tender concerns the conclusion of a non-exclusive rebate agreement for the medicine Roxadustat (ATC B03XA05) for the period 01/06/2026 to 31/05/2028. It is an open accession model, meaning interested pharmaceutical companies may join on the stated terms if they submit the required documents by email on time. The bidder should note that the exact qualification and exclusion requirements are only partly available in the machine-readable notice and must be checked in the tender documents.